SIGA Stock (NASDAQ:SIGA)
Previous Close
$7.87
52W Range
$4.26 - $12.83
50D Avg
$9.02
200D Avg
$7.31
Market Cap
$563.82M
Avg Vol (3M)
$1.44M
Beta
0.91
Div Yield
$0.60 (7.59%)
SIGA Company Profile
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
SIGA Performance
Peer Comparison
| Ticker | Company |
|---|---|
| ELAN | Elanco Animal Health Incorporated |
| RDY | Dr. Reddy's Laboratories Limited |
| ESPR | Esperion Therapeutics, Inc. |
| PAHC | Phibro Animal Health Corporation |
| ORGO | Organogenesis Holdings Inc. |
| NBIX | Neurocrine Biosciences, Inc. |
| IRWD | Ironwood Pharmaceuticals, Inc. |
| ALIM | Alimera Sciences, Inc. |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. |
| SSIC | Silver Spike Investment Corp. |
| PTPI | Petros Pharmaceuticals, Inc. |
| DCPH | Deciphera Pharmaceuticals, Inc. |
| LSDI | Lucy Scientific Discovery Inc. |
| ALKS | Alkermes plc |
| PCRX | Pacira BioSciences, Inc. |
| COLL | Collegium Pharmaceutical, Inc. |
| CTLT | Catalent, Inc. |
| SXTC | China SXT Pharmaceuticals, Inc. |
| AVDL | Avadel Pharmaceuticals plc |